Coronary Ectasia and ST Elevation Myocardial Infarction Patients: Does Atherosclerosis Influence Periprocedural

Victorine Fraichot1, Jeanne Varlot1, Florian Eggenspieler1

  • 1Department of Cardiology, Université de Lorraine, CHRU-Nancy, Nancy, France.

Insights

Patients with ST-elevation myocardial infarction (STEMI) and coronary artery ectasia (CAE) show different procedural outcomes based on the presence of coronary atherosclerosis. This study highlights distinct periprocedural characteristics, influencing treatment strategies.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Coronary artery ectasia (CAE) impacts procedural outcomes in ST-elevation myocardial infarction (STEMI).
  • The relationship between CAE and atherosclerotic coronary artery disease (ACAD) in STEMI patients is not well-defined.
  • Understanding these associations is crucial for optimizing patient management.

Purpose of the Study:

  • To compare clinical and procedural characteristics of STEMI patients with CAE.
  • To evaluate outcomes in STEMI patients with CAE, stratified by the presence or absence of coexisting ACAD.
  • To identify differences in periprocedural management and outcomes between isolated CAE and CAE with ACAD.

Main Methods:

  • A cohort of 148 STEMI patients with ectatic infarct-related arteries undergoing primary percutaneous intervention (PCI) was analyzed.
  • Patients were divided into two groups: isolated CAE (n=74) and CAE with coexisting ACAD (n=74).
  • Clinical data, procedural details, and 3-year follow-up outcomes were compared between the groups.

Main Results:

  • Patients with CAE and ACAD were older and underwent more frequent coronary angioplasty and stenting compared to those with isolated CAE.
  • A trend towards less frequent distal embolization was observed in the CAE with ACAD group.
  • No significant differences were found in cardiac enzyme levels, left ventricular ejection fraction, or 3-year major adverse cardiovascular event (MACE)-free rates between the groups.

Conclusions:

  • STEMI patients with ectatic infarct-related arteries exhibit distinct periprocedural characteristics based on the presence of coronary atherosclerosis.
  • The findings suggest that coexisting ACAD influences procedural interventions in STEMI patients with CAE.
  • Further research is warranted to establish optimal therapeutic strategies for these patients at discharge.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
71
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
22
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29